Search Result "SARS 3C-like proteinase"
Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 3 Year: 2006 Page: 4555-4564
Author(s): Luhua Lai, Xiaofeng Han, Hao Chen, Ping Wei, Changkang Huang, Shiyong Liu, Keqiang Fan, Lu Zhou, Zhenming Liu, Jianfeng Pei, Ying Liu
Recent Developments on Coronavirus Main Protease/3C Like Protease Inhibitors
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 8 Issue: 2 Year: 2013 Page: 150-156
Author(s): Qi Zhao, Erin Weber, Haitao Yang
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 6 Year: 2021 Page: 442-460
Author(s): Dima A. Sabbah,Rima Hajjo,Sanaa K. Bardaweel,Haizhen A. Zhong
Characterization and Inhibition of SARS-Coronavirus Main Protease
Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 4 Year: 2006 Page: 361-376
Author(s): Po-Huang Liang
SARS Coronavirus Anti-Infectives
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 297-308
Author(s): Tommy R. Tong
SARS Coronavirus Anti-Infectives
Ebook: Frontiers in Anti-Infective Drug Discovery
Volume: 1 Year: 2010
Author(s): Tommy R. Tong
Doi: 10.2174/978160805158811001010083
An Overall Picture of SARS Coronavirus (SARS-CoV) Genome-Encoded Major Proteins: Structures, Functions and Drug Development
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 3 Year: 2006 Page: 4539-4553
Author(s): Shuai Chen, Haibin Luo, Lili Chen, Jing Chen, Jianhua Shen, Weiliang Zhu, Kaixian Chen, Xu Shen, Hualiang Jiang
Recent Patents on Treatment of Severe Acute Respiratory Syndrome (SARS)
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 2 Issue: 1 Year: 2007 Page: 1-10
Author(s): Shumei Zhai, Wei Liu, Bing Yan
SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
Journal: Current Molecular Medicine
Volume: 22 Issue: 1 Year: 2022 Page: 50-66
Author(s): Mohammed Elimam Ahamed Mohammed
Peptidomimetic and Peptide-Derived Against 3CLpro from Coronaviruses
Ebook: Pharmaceuticals for Targeting Coronaviruses
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815051308122010007